NVO, UBS, ASML: European Stocks Close at Record Highs as Inflation Retreats
European stock markets closed at or near record highs on March 3 as economic data showed inflation continuing to decline across the continent, ...
Novo Holdings and TA Associates back Biocomposites
Novo Holdings’ investment alongside Biocomposites’ existing shareholder, TA Associates, will help the company scale its ...
The UK16h
Medical device firm secures investment to accelerate global expansion
A medical device company has secured investment from the owner of the developer of Ozempic and a private equity firm, to ...
FierceBiotech18h
Frazier arms Callio with $187M series A to fly Hummingbird's HER2 dual payload ADC to clinic
Frazier Life Sciences has launched Callio Therapeutics with $187 million in series A funds and a HER2-targeted dual-payload ...
ig.com19h
Aspen Pharmacare H1 2025: strong growth despite currency & tax challenges
Analysis of Aspen Pharmacare's H1 2025 results. Revenue up, EBITDA strong, focus on GLP-1s & sterile manufacturing. Learn ...
Novo Nordisk downgraded to Hold from Buy at Stifel
Stifel downgraded Novo Nordisk (NVO) to Hold from Buy with a price target of DKK 700, down from DKK 780. Novo is “no longer the same stock that ...
PE Hub22h
Novo Holdings, TA Associates agree Biocomposites investment
Novo Holdings and TA Associates have agreed to make an investment into Biocomposites.
Novo Holdings and TA Associates partner with Biocomposites to drive next chapter of its growth
Novo Holdings and TA Associates ("TA"), announced today that the parties have entered into an agreement for Novo Holdings to make an investment in Biocomposites ("the Company"), an international ...
Biocomposites; Novo Holdings; TA Associates: Novo Holdings and TA Associates partner with Biocomposites to drive next chapter of its growth
Additional investment and resources will accelerate Biocomposites' international expansion and innovation in products for use in infection management HELLERUP, Denmark, LONDON and KEELE ...